Confidence Beyond Compliance
With just 6 months to go before the UK’s withdrawal from the EU and the start of the implementation (transitional) phase, the clock is ticking for the pharma and biopharma industries to review their contingency plans. At PharmaLex our expertise covers all aspects of regulatory affairs, pharmacovigilance, supply chain and compliance. With offices in the EU27 and the UK, we are keeping abreast of developments in relation to both future EU and UK regulatory intelligence.
Contact us to discuss how we can help you in these challenging times.